Healthy Clinical Trial
— e-VOG(YA)Official title:
Eye Movements Recording Using a Smartphone: Comparison to Standard Video-oculography Data in Young Athletes
Verified date | May 2022 |
Source | Association de Recherche Bibliographique pour les Neurosciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study aims to compare measurements obtained through the e-VOG application (mobile application, usable on smartphones or tablets, to measure eye movements) with measurements from the standard video-oculography device (Eye-Tracker®T2), in young athletes.
Status | Completed |
Enrollment | 46 |
Est. completion date | February 22, 2022 |
Est. primary completion date | February 22, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 15 Years to 20 Years |
Eligibility | Inclusion Criteria: - Young Athletes from AS Monaco Football Academy - referred by AS Monaco Medical Team to perform a video-oculography (Eye-Tracking) examination as part of routine care. - covered by a health insurance system - volunteer, able to give free, informed and written consent. - For minors: whose holder of parental authority has given their written consent to participate following the information given by investigator. Exclusion Criteria: - General anaesthesia within 3 months. - Head trauma within 3 months - Neurological, ophthalmological or general pathology preventing the realization of a video-oculography examination. - Oculomotor abnormality detectable on clinical examination by the neurologist prescribing the standard video-oculography examination. |
Country | Name | City | State |
---|---|---|---|
Monaco | Centre Mémoire / Centre de Gérontologie Clinique Rainier III / Princess Grace Hospital | Monaco |
Lead Sponsor | Collaborator |
---|---|
Association de Recherche Bibliographique pour les Neurosciences | Association Sportive Monaco Football Club, Centre Hospitalier Princesse Grace, Centre Hospitalier Universitaire de Nice |
Monaco,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Oculomotor profiles concordance | Analyze of the concordance of the profiles obtained between the e-VOG digital assessment and the standard video-oculography assessment.
Evaluation criteria: For each assessment, patients will be classified according to the number of oculomotor abnormality observed (based on identified parameters assessments: latency / speed / gain / altered ocular pursuits / fixation disorders / presence of internuclear ophthalmoplegia), in accordance with the literature standards. |
Day 0 | |
Secondary | Latency during horizontal reflex saccades | Measure of Latency during an horizontal reflex saccades paradigm with e-VOG Compared to the one performed with standard video-oculography device.
Evaluation criteria: latency (reaction time in ms). |
Day 0 | |
Secondary | Latency during vertical reflex saccades | Measure of Latency during a vertical reflex saccades paradigm with e-VOG Compared to the one performed with standard video-oculography device.
Evaluation criteria: latency (reaction time in ms). |
Day 0 | |
Secondary | Latency during horizontal voluntary saccades | Measure of Latency during an horizontal volontary saccades paradigm with e-VOG Compared to the one performed with standard video-oculography device.
Evaluation criteria: latency (reaction time in ms). |
Day 0 | |
Secondary | Velocity during horizontal reflex saccades | Measure of Velocity during an horizontal reflex saccades paradigm with e-VOG Compared to the one performed with standard video-oculography device.
Evaluation criteria: velocity (mean and peak velocity) in °/s. |
Day 0 | |
Secondary | Velocity during vertical reflex saccades | Measure of Velocity during a vertical reflex saccades paradigm with e-VOG Compared to the one performed with standard video-oculography device.
Evaluation criteria: velocity (mean and peak velocity) in °/s. |
Day 0 | |
Secondary | Inhibition capacity | Measure of inhibition capacity performance during an antisaccades" paradigm with e-VOG Compared to the one evaluated with standard video-oculography device.
Evaluation criteria: percentage of errors. |
Day 0 | |
Secondary | Internuclear ophthalmoplegia (INO) detection | Highlight presence/absence of INO with e-VOG Compared to standard video-oculography device.
Evaluation criteria: INO is present if calculated ratio of abducting to adducting eye movement (both mean and peak velocity) is >1. |
Day 0 | |
Secondary | Fixations impairments detection | Highlight presence/absence of Fixations impairments with e-VOG Compared to standard video-oculography device.
Evaluation criteria: presence/absence/frequency of square wave-jerks, nystagmus, flutters. |
Day 0 | |
Secondary | Impairment of horizontal smooth pursuit | Highlight Impairment of horizontal smooth pursuit with e-VOG Compared to standard video-oculography device.
Evaluation criteria: presence/absence of saccade and perturbation. |
Day 0 | |
Secondary | Impairment of vertical smooth pursuit | Highlight Impairment of horizontal smooth pursuit with e-VOG Compared to standard video-oculography device.
Evaluation criteria: presence/absence of saccade and perturbation. |
Day 0 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |